ABCs of pain: F is for….
July 6, 2008 by Marijke Durning, RN
Filed under Diseases & Conditions
And for pain, it’s also for:
Fibromyalgia: An autoimmune disease, one where the body attacks itself, fibromyalgia is still a very unknown, misunderstood disease that attacks mostly women. Some good links for fibromyalgia are:
Questions and Answers about Fibromyalgia
Fibromyalgia (Mayo Clinic)
Fibromyalgia(American College of Rheumatology)
Facet Joint Syndrome: A major cause of back pain, facet joint syndrome or facet joint disorder, is caused by the inflammation of the facet joints in the spine. These sites explain it well:
Facet Joint Syndrome (Cleveland Clinic)
Facet Joint Syndrome (Spine Universe)
Image: Newscom
~~~~~~
Don’t forget the Pain Relief book give away, ending July 14th:
Pain Relief book give away
~~~~
Pain Relief book give away
June 30, 2008 by Marijke Durning, RN
Filed under Diseases & Conditions
As part of my blogging and writing about pain for this blog and pregnancy for Womb Within, I get to review books and products that I can recommend (if I like them) and sometimes offer as give aways to my readers.
I have a book here called The Art of Body Maintenance: Winner’s Guide to Pain Relief, by Hal Blatman, MD, with art done by Brad Ekvall, BFA.
It’s a nice book with lots of detail and diagrams. The program also uses a rubber ball to help apply pressure to relieve chronic pain.
The author covers pain relief from fibromyalgia, myofascial pain …read more
Press Release: FDA Approves Cymbalta for Management of Fibromyalgia
June 16, 2008 by Marijke Durning, RN
Filed under Diseases & Conditions
Cymbalta Reduces Pain and Improves Functioning in Fibromyalgia Patients
INDIANAPOLIS, June 16 /PRNewswire-FirstCall/ — The U.S. Food and Drug Administration (FDA) has approved Cymbalta(R) (duloxetine HCl) for the management of fibromyalgia, a chronic widespread pain disorder, Eli Lilly and Company (NYSE: LLY) announced today. Cymbalta is the first serotonin-norepinephrine reuptake inhibitor with proven efficacy for reducing pain inpatients with fibromyalgia. The fibromyalgia indication represents thesecond FDA-approved use for Cymbalta for a pain disorder, demonstrating the medication’s analgesic effect.
“The approval of Cymbalta is important because it provides physicians and patients with a new treatment option shown to help reduce pain and improve …read more
